ELDN Operating Cash Flow Growth
Eledon Pharmaceuticals Inc · Operating Cash Flow Growth
ELDN Operating Cash Flow Growth
Year-over-year change vs the same period a year earlier
Latest reported-28.02%period ending
ELDN Quarterly Cash from Operations YoY % (-49.75% → -28.02%)
Year-over-year change
High-resolution chart · PNG
ELDN operating cash flow growth history
Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | Operating Cash Flow Growth |
|---|---|
| -28.0246% | |
| -40.797% | |
| 25.7861% | |
| -23.0096% | |
| -127.8492% | |
| -83.7318% | |
| -107.94% | |
| 3.9344% | |
| 5.4373% | |
| 11.9206% | |
| 3.6814% | |
| -168.0158% | |
| -32.2342% | |
| -21.6773% | |
| -2.954% | |
| 35.5562% | |
| 16.5055% | |
| -57.8784% | |
| 2.3852% | |
| -1,164.3494% | |
| -146.4747% | |
| -135.1388% | |
| -366.2877% | |
| 80.5815% | |
| 38.6225% | |
| 45.389% | |
| 39.666% | |
| 1.5673% | |
| -47.6305% | |
| -77.1466% | |
| -28.4182% | |
| 14.1059% | |
| 42.1683% | |
| 27.859% | |
| 64.2818% | |
| 62.7494% | |
| 44.0128% | |
| 67.6797% | |
| 17.6524% | |
| 10.5073% | |
| 6.4334% | |
| 12.2839% | |
| -37.4149% | |
| -129.6147% | |
| -103.0068% | |
| -132.4958% | |
| 5.2925% | |
| -49.7484% |